Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects

Lancet

Volumn 355, Issue 9200, 2000, Pages 299-304

  Leonard, J V ^a,b   Schapira, A H V ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

APOPTOSIS; CELL METABOLISM; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; HUMAN; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; REVIEW;

EID: 0034700807     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05225-3     Document Type: Review

References (34)

1. Anderson S., Bankier A.T., Barrell B.G.et al. Sequence and organization of the human mitochondrial genome. Nature. 290:1981;457-465.
2. Taanman J.W. The human mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta. 1410:1999;103-123.
3. Brown G.K. Bottlenecks and beyond: mitochondrial DNA segregation in health and disease. J Inherit Metab Dis. 20:1997;2-8.
4. Hauswirth W.W., Laipis P.J. Mitochondrial DNA polymorphism in a maternal lineage of Holstein cows. Proc Natl Acad Sci USA. 79:1982;4686-4690.
5. Hayashi J.-I., Ohta S., Kikuchi A., Takemitsu M., Goto Y.-I., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA. 88:1991;10614-10618.
6. Chomyn A., Martinuzzi A., Yoneda M.et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature trascripts. Proc Natl Acad Sci USA. 89:1992;4221-4225.
7. Johnston W., Karpati G., Carpenter S., Arnold D., Shoubridge E.A. Late-onset mitochondrial myopathy. Ann Neurol. 37:1995;16-23.
8. Sue C.M., Crimmins D.S., Soo Y.S.et al. Neuroradiological features of six kindreds with MELAS tRNA (Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry. 65:1998;233-240.
9. Hasegawa H., Matsuoka T., Goto Y.et al. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol. 29:1991;601-605.
10. Hammans S.R., Sweeney M.G., Brockington M.et al. The mitochondrial DNA transfer RNA (Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain. 116:1993;617-632.
11. Rahman S., Blok R.B., Dahl H.H.et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 39:1996;343-351.
12. Harding A.E., Sweeney M.G., Govan G.G., Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet. 57:1995;77-86.
13. Jun A.S., Brown M.D., Wallace D.C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA. 91:1994;6206-6210.
14. De Vries D.D., Went L.N., Bruyn G.W.et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet. 58:1996;703-711.
15. Riordan-Eva P., Sander M., Govan G.G., Sweeney M.G., Da Costa J., Harding A.E. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 118:1995;319-337.
16. Chalmers R.M., Davis M.B., Sweeney M.G.et al. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet. 59:1996;103-108.
17. Smith P.R., Cooper J.M., Govan G.G.et al. Antibodies to human optic nerve in Leber's hereditary optic neuropathy. J Neurol Sci. 130:1995;134-138.
18. Govan G.G., Smith P.R., Kellar-Wood H., Schapira A.H.V., Harding A.E. HLA class II genotypes in Leber's hereditary optic neuropathy. J Neurol Sci. 126:1994;193-196.
19. Chalmers R.M., Govan G.G., Schapira A.H.V., Harding A.E. HLA class I genotypes in Leber's hereditary optic neuropathy. J Neurol Sci. 135:1996;173-175.
20. Harding A.E., Sweeney M.G., Miller D.H.et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain. 155:1992;979-989.
21. McShane M.A., Hammans S.R., Sweeney M.et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet. 48:1991;39-42.
22. Holt I.J., Harding A.E., Cooper J.M.et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol. 26:1989;699-708.
23. Campos Y., Garcia-Silva T., Barrioneuvo C.R., Cabello A., Muley R., Arenas J. Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis and stroke-like episodes (MELAS) and Fanconi's syndrome. Pediatr Neurol. 13:1995;69-72.
24. Poulton J., Deadman M.E., Bindoff L.et al. Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet. 2:1993;23-30.
25. Manfredi G., Vu T., Bonilla E.et al. Association of myopathy with large-scale mitochondrial DNA duplications and deletions: which is pathogenic? Ann Neurol. 42:1997;180-188.
26. Servidei S. Mitochondrial encephalomyelopathies: gene mutations. Neuromusc Disord. 8:1998;13-17.
27. Cock H.C., Cooper S.J., Schapira A.H.V. Functional consequences of the 3460bp mitochondrial DNA mutation associated with LHON. J Neurol Sci. 165:1999;10-17.
28. Cock H.C., Tabrizi S.J., Cooper J.M., Schapira A.H.V. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy. Ann Neurol. 44:1998;187-193.
29. Morris A.A.M., Leonard J.V. Treatment of congenital lactic acidoses. J Inherit Metab Dis. 19:1996;573-580.
30. Chinnery P.G., Howell N., Lightowlers R.N., Turnbull D.M. Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotypes. Brain. 120:1997;1713-1721.
31. Mackey D., Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet. 51:1992;1218-1228.
32. Clark K.M., Watt D.J., Lightowlers R.N., Johnson M.A., Relvas J.B., Taanman J.-W. SCID mice containing muscle with human mitochondrial DNA mutations: an animal model for mitochondrial DNA defects. J Clin Invest. 102:1998;2090-2095.
33. Taylor R.W., Chinnery P.F., Clark K.M.et al. Treatment of mitochondrial disease. J Bioenerg Biomembr. 29:1997;195-205.
34. Chinnery P.F., Howell N., Lightowlers R.N., Turnbull D.M. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain. 121:1998;1889-1894.